Intranasal human growth hormone (hGH) induces IGF-I levels comparable to subcutaneous injection with lower systemic exposure to hGH in healthy volunteers.
AffiliationCritical Pharmaceuticals Limited, BioCity Nottingham, Pennyfoot St, Nottingham
MetadataShow full item record
AbstractThe development of an improved, efficacious hGH product administered by a non-injectable route of delivery such as the nasal route is highly desirable. We have developed a novel nasal hGH product (CP024) that showed excellent nasal absorption in animal models, however translation of these results into the clinical setting is essential, as past attempts to develop such formulations by other groups have been unable to induce IGF-1 in man.
CitationIntranasal human growth hormone (hGH) induces IGF-I levels comparable to subcutaneous injection with lower systemic exposure to hGH in healthy volunteers. 2015:jc20144146 J Clin Endocrinol Metab
JournalJournal of Clinical Endocrinology and Metabolism
- Bioavailability and bioactivity of three different doses of nasal growth hormone (GH) administered to GH-deficient patients: comparison with intravenous and subcutaneous administration.
- Authors: Laursen T, Grandjean B, Jørgensen JO, Christiansen JS
- Issue date: 1996 Sep
- A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile.
- Authors: Rasmussen MH, Olsen MW, Alifrangis L, Klim S, Suntum M
- Issue date: 2014 Oct
- Relative Bioavailability of a Single 4-mg Dose of Somatropin Administered by Subcutaneous Injection or by Needle-free Device and Coadministered With the Growth Hormone Inhibitor Octreotide Acetate in Healthy Adult Subjects.
- Authors: Brimhall DB, Petri N, D'Angelo P
- Issue date: 2018 May
- Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation.
- Authors: Vlugt-Wensink KD, de Vrueh R, Gresnigt MG, Hoogerbrugge CM, van Buul-Offers SC, de Leede LG, Sterkman LG, Crommelin DJ, Hennink WE, Verrijk R
- Issue date: 2007 Dec
- Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle.
- Authors: Brearley C, Priestley A, Leighton-Scott J, Christen M
- Issue date: 2007 Oct 8